Crosstalk between Dopamine D2 receptors and cannabinoid CB1 receptors regulates CNR1 promoter activity via ERK1/2 signaling

被引:20
|
作者
Chiang, Yao-Chang [1 ,2 ]
Lo, Yan-Ni [3 ]
Chen, Jin-Chung [3 ]
机构
[1] China Med Univ Hosp, Ctr Drug Abuse & Addict, Taichung, Taiwan
[2] China Med Univ, Taichung, Taiwan
[3] Chang Gung Univ, Dept Physiol & Pharmacol, Neuropharmacol Lab, Tao Yuan 333, Kwei Shan, Taiwan
关键词
5 '-untranslated region; cannabinoid CB1 receptor; dopamine D-2 receptor; ERK1/2; gene regulation; promoter structure; D2; RECEPTORS; HUNTINGTONS-DISEASE; PROTEIN-KINASE; TRANSCRIPTIONAL REGULATION; CONCURRENT STIMULATION; ADENOSINE A(2A); ISOFORMS; ACTIVATION; EXPRESSION; RAT;
D O I
10.1111/jnc.12399
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previously, we found that chronic methamphetamine treatment altered cannabinoid type 1 receptor (CB1R)-dependent cAMP/PKA/dopamine and cAMP-regulated phosphoprotein of Mr 32000 (DARPP-32)/T34/PP2B signaling and decreased levels of CB1R protein and mRNA in the nucleus accumbens. These findings suggested the existence of signaling interplay between mesolimbic dopamine and CB1R. In this study, we further investigate interactions between CB1R and dopamine D2 receptor (D2R) signaling. Activation of either CB1R or D2R increased extracellular signal-regulated kinases 1 and 2 (ERK1/2) phosphorylation, while co-stimulation of CB1R and D2R evoked an additive effect on the phospho-ERK1/2 signal. This effect was mediated through a pertussis toxin-sensitive Gi/o pathway in primary striatal cells. Furthermore, the mRNA level of CB1R was increased via dopamine D2 receptor short form (D2SR) by treatment with D2R agonist quinpirole in D2SR/C6 glioma cells. This effect could be suppressed by co-treatment with the ERK1/2 inhibitor U0126. To test if D2SR could transcriptionally regulate CB1R, the 5-untranslated region (5-UTR) of the cannabinoid receptor 1 (CNR1) gene was sequenced from rat brain. Results showed that the CNR1 gene includes two exons, which contain 375bp of 5-UTR and are separated by a 17-kb intron. A luciferase reporter assay showed that the maximal D2SR-responsive promoter activity is located in the -1 to -222 region of CNR1 promoter. Overall, we demonstrate previously unidentified crosstalk between D2R and CB1R via ERK1/2 signaling that enhances the expression of CB1R by modulating its promoter activity.
引用
收藏
页码:163 / 176
页数:14
相关论文
共 50 条
  • [31] Physical and functional interaction between CB1 cannabinoid receptors and β2-adrenoceptors
    Hudson, Brian D.
    Hebert, Terence E.
    Kelly, Melanie E. M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (03) : 627 - 642
  • [32] Decoding the Signaling through Homomeric and Heteromeric Cannabinoid CB1 Receptors
    Xiang, Guoqing
    Kawano, Takeharu
    Baki, Apostolia
    Logothetis, Diomedes
    BIOPHYSICAL JOURNAL, 2017, 112 (03) : 88A - 88A
  • [33] Cannabinoid CB1 Receptors Activation and Coactivation With D2 Receptors Modulate GABAergic Neurotransmission in the Globus Pallidus and Increase Motor Asymmetry
    Munoz-Arenas, Guadalupe
    Paz-Bermudez, Francisco
    Baez-Cordero, Ana
    Caballero-Floran, Rene
    Gonzalez-Hernandez, Brenda
    Floran, Benjamin
    Daniel Limon, I.
    SYNAPSE, 2015, 69 (03) : 103 - 114
  • [34] Induction of Proteinuria by Cannabinoid Receptors 1 Signaling Activation in CB1 Transgenic Mice
    Hsu, Yung-Chien
    Lei, Chen-Chou
    Shih, Ya-Hsueh
    Ho, Cheng
    Lin, Chun-Liang
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 349 (02): : 162 - 168
  • [35] CB1 and CB2 cannabinoid receptors are implicated in inflammatory hypersensitivity to pain
    Clayton, NM
    O'Shaughnessy, CT
    Marshall, F
    Bountra, C
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134
  • [36] Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB1 and CB2 receptors
    Govaerts, SJ
    Muccioli, GG
    Hermans, E
    Lambert, DM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 495 (01) : 43 - 53
  • [37] Roles of cannabinoid CB1 and CB2 receptors in the modulation of psychostimulant responses
    Gobira, P. H.
    Joca, S. R.
    Moreira, F. A.
    ACTA NEUROPSYCHIATRICA, 2024, 36 (02) : 67 - 77
  • [38] Pharmacological characterization of novel ligands for CB1 and CB2 cannabinoid receptors
    Thermos, K.
    Papazoglou, M.
    Antoniou, K.
    Mastrodimou, N.
    Panagis, G.
    Vlachou, S.
    Renieri, E.
    Nahmias, V.
    Menissiou, A.
    Gianni, M.
    Kondylis, M. P.
    Daifoti-Papadopoulou, Z.
    Papahatjis, D.
    Spyraki, C.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 394 - 395
  • [39] Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain
    Callen, Lucia
    Moreno, Estefania
    Barroso-Chinea, Pedro
    Moreno-Delgado, David
    Cortes, Antoni
    Mallol, Josefa
    Casado, Vicent
    Luis Lanciego, Jose
    Franco, Rafael
    Lluis, Carmen
    Canela, Enric I.
    McCormick, Peter J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (25) : 20851 - 20865
  • [40] Capsaicin evokes hypothermia independent of cannabinoid CB1 and CB2 receptors
    Ding, Z
    Cowan, A
    Rawls, SM
    BRAIN RESEARCH, 2005, 1065 (1-2) : 147 - 151